DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 163 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,000 | +29.8% | 11,697 | +44.5% | 0.00% | – |
| Q2 2023 | $114,000 | +17.5% | 8,095 | +29.1% | 0.00% | – |
| Q1 2023 | $97,000 | -34.0% | 6,271 | -30.3% | 0.00% | – |
| Q4 2022 | $147,000 | +1370.0% | 8,998 | +1492.6% | 0.00% | – |
| Q3 2022 | $10,000 | +233.3% | 565 | +123.3% | 0.00% | – |
| Q2 2022 | $3,000 | -87.0% | 253 | -89.6% | 0.00% | – |
| Q1 2022 | $23,000 | -72.3% | 2,443 | -71.3% | 0.00% | – |
| Q4 2021 | $83,000 | +361.1% | 8,523 | +1542.2% | 0.00% | – |
| Q3 2021 | $18,000 | +800.0% | 519 | +1053.3% | 0.00% | – |
| Q2 2021 | $2,000 | -97.9% | 45 | -97.9% | 0.00% | – |
| Q1 2021 | $97,000 | +9600.0% | 2,164 | +8556.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 25 | -28.6% | 0.00% | – |
| Q2 2020 | $2,000 | -95.1% | 35 | -96.5% | 0.00% | – |
| Q1 2020 | $41,000 | -66.1% | 1,010 | -48.2% | 0.00% | – |
| Q4 2019 | $121,000 | +1412.5% | 1,948 | +471.3% | 0.00% | – |
| Q2 2019 | $8,000 | -20.0% | 341 | +28.2% | 0.00% | – |
| Q3 2018 | $10,000 | +400.0% | 266 | +358.6% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 58 | -28.4% | 0.00% | – |
| Q4 2017 | $2,000 | – | 81 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |